AFPL
BIIB icon

Advus Financial Partners, LLC’s Biogen BIIB Stock Holding History

Advus Financial Partners, LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Sell
2,566
-56
-2% -$10.7K 0.13% 117
2026
Q1 		$481K Buy
2,622
+492
+23% +$90.7K 0.12% 126
2025
Q4 		$375K Buy
2,130
+60
+3% +$9.8K 0.09% 160
2025
Q3 		$290K Buy
+2,070
New +$280K 0.07% 202

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advus Financial Partners, LLC's BIIB Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Biogen (BIIB) stake by 2.1% in Q2 2026, selling an estimated $10.7K and leaving 2,566 shares worth $554K. The position accounts for 0.13% of the portfolio, ranked #117.

Advus Financial Partners, LLC first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Advus Financial Partners, LLC held 2,566 shares of Biogen worth $554K as of Q2 2026.
  • Advus Financial Partners, LLC sold 56 Biogen shares in Q2 2026, an estimated $10.7K.
  • Biogen made up 0.13% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #117 holding.
  • Advus Financial Partners, LLC first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,040 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.